These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29661516)

  • 1. Lisdexamfetamine Targets Amygdala Mechanisms That Bias Cognitive Control in Attention-Deficit/Hyperactivity Disorder.
    Schulz KP; Krone B; Adler LA; Bédard AV; Duhoux S; Pedraza J; Mahagabin S; Newcorn JH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Aug; 3(8):686-693. PubMed ID: 29661516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanfacine modulates the emotional biasing of amygdala-prefrontal connectivity for cognitive control.
    Schulz KP; Clerkin SM; Newcorn JH; Halperin JM; Fan J
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1444-53. PubMed ID: 25059532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emotional bias of cognitive control in adults with childhood attention-deficit/hyperactivity disorder.
    Schulz KP; Bédard AC; Fan J; Clerkin SM; Dima D; Newcorn JH; Halperin JM
    Neuroimage Clin; 2014; 5():1-9. PubMed ID: 24918067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amygdala-prefrontal cortical functional connectivity during implicit emotion processing differentiates youth with bipolar spectrum from youth with externalizing disorders.
    Hafeman D; Bebko G; Bertocci MA; Fournier JC; Chase HW; Bonar L; Perlman SB; Travis M; Gill MK; Diwadkar VA; Sunshine JL; Holland SK; Kowatch RA; Birmaher B; Axelson D; Horwitz SM; Arnold LE; Fristad MA; Frazier TW; Youngstrom EA; Findling RL; Phillips ML
    J Affect Disord; 2017 Jan; 208():94-100. PubMed ID: 27756046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
    Adler LA; Dirks B; Deas PF; Raychaudhuri A; Dauphin MR; Lasser RA; Weisler RH
    J Clin Psychiatry; 2013 Jul; 74(7):694-702. PubMed ID: 23945447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal amygdalar activation and connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Posner J; Nagel BJ; Maia TV; Mechling A; Oh M; Wang Z; Peterson BS
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):828-37.e3. PubMed ID: 21784302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study.
    Weisler R; Ginsberg L; Dirks B; Deas P; Adeyi B; Adler LA
    J Atten Disord; 2017 Dec; 21(14):1198-1207. PubMed ID: 24464328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amygdala reactivity and ventromedial prefrontal cortex coupling in the processing of emotional face stimuli in attention-deficit/hyperactivity disorder.
    Viering T; Naaijen J; van Rooij D; Thiel C; Philipsen A; Dietrich A; Franke B; Buitelaar J; Hoekstra PJ
    Eur Child Adolesc Psychiatry; 2022 Dec; 31(12):1895-1907. PubMed ID: 34120213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological basis of reinforcement-based decision making in adults with ADHD treated with lisdexamfetamine dimesylate: Preliminary findings and implications for mechanisms influencing clinical improvement.
    Newcorn JH; Ivanov I; Krone B; Li X; Duhoux S; White S; Schulz KP; Bédard AV; Pedraza J; Adler L; Blair RJ
    J Psychiatr Res; 2024 Feb; 170():19-26. PubMed ID: 38101205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive attention control and emotional responding in attention-deficit/hyperactivity disorder--A functional MRI study.
    Hwang S; White SF; Nolan ZT; Craig Williams W; Sinclair S; Blair RJ
    Neuroimage Clin; 2015; 9():545-54. PubMed ID: 26640766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control.
    Schulz KP; Clerkin SM; Fan J; Halperin JM; Newcorn JH
    Psychopharmacology (Berl); 2013 Mar; 226(2):261-71. PubMed ID: 23086020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.
    Katic A; Dirks B; Babcock T; Scheckner B; Adeyi B; Richards C; Findling RL
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):386-93. PubMed ID: 23952185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD.
    Adler LA; Leon TL; Sardoff TM; Krone B; Faraone SV; Silverstein MJ; Newcorn JH
    J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34232582
    [No Abstract]   [Full Text] [Related]  

  • 14. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder.
    Bottelier MA; Schrantee A; Ferguson B; Tamminga HGH; Bouziane C; Kooij JJS; de Ruiter MB; Reneman L
    Psychiatry Res Neuroimaging; 2017 Nov; 269():36-42. PubMed ID: 28938219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisdexamfetamine: A Review in ADHD in Adults.
    Frampton JE
    CNS Drugs; 2016 Apr; 30(4):343-54. PubMed ID: 27048350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
    Brams M; Weisler R; Findling RL; Gasior M; Hamdani M; Ferreira-Cornwell MC; Squires L
    J Clin Psychiatry; 2012 Jul; 73(7):977-83. PubMed ID: 22780921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay aversion in attention deficit/hyperactivity disorder is mediated by amygdala and prefrontal cortex hyper-activation.
    Van Dessel J; Sonuga-Barke E; Mies G; Lemiere J; Van der Oord S; Morsink S; Danckaerts M
    J Child Psychol Psychiatry; 2018 Aug; 59(8):888-899. PubMed ID: 29427289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional neuroimaging abnormalities in youth with psychosis spectrum symptoms.
    Wolf DH; Satterthwaite TD; Calkins ME; Ruparel K; Elliott MA; Hopson RD; Jackson CT; Prabhakaran K; Bilker WB; Hakonarson H; Gur RC; Gur RE
    JAMA Psychiatry; 2015 May; 72(5):456-65. PubMed ID: 25785510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
    Adler LA; Goodman DW; Kollins SH; Weisler RH; Krishnan S; Zhang Y; Biederman J;
    J Clin Psychiatry; 2008 Sep; 69(9):1364-73. PubMed ID: 19012818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Lateral Prefrontal Cortex Functioning During Emotional Interference Resistance Is Associated With Affect Lability in Adults With Persisting Symptoms of Attention-Deficit/Hyperactivity Disorder From Childhood.
    Ojha A; Jones NP; Henry T; Versace A; Gnagy EM; Joseph HM; Molina BSG; Ladouceur CD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jun; 9(6):588-596. PubMed ID: 38378127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.